
World wide shipping
online service for 24 x 7
Updated Product Catalog

CAS No. : [136451-58-6]
IUPAC Name : 2-(3-(2-(4,5-Diphenyloxazol-2-yl)ethyl)phenoxy)acetic acid
| Price And Availability | ||||
|---|---|---|---|---|
| Pack Size | Price in USD | Add To Shopping Cart | Availability | Shipping Status |
| 5MG | Request A Quote | Back Order | Estimated to ship on 04 October 2026 | |
| 10MG | Request A Quote | Back Order | Estimated to ship on 04 October 2026 | |
| 25MG | Request A Quote | Back Order | Estimated to ship on 04 October 2026 | |
| 50MG | Request A Quote | Back Order | Estimated to ship on 04 October 2026 | |
| 100MG | Request A Quote | Back Order | Estimated to ship on 04 October 2026 | |
| 250MG | Request A Quote | Back Order | Estimated to ship on 04 October 2026 | |
| 500MG | Request A Quote | Back Order | Estimated to ship on 04 October 2026 | |
![]() | ||||
| Note: BMY-42393is not in stock but can be available through custom synthesis. The estimated lead-time is 4-6 weeks. The product will be characterized by NMR and Mass analysis. Purity (HPLC) is usually >98%. COA, QC data and SDS will be provided along with the product. For information on pricing and availability please contact us at sales@syninnova.com or Request A Quote. We respond promptly. Thank You! | ||||
| Chemical Properites | |
|---|---|
Mol. Formula : C25H21NO4 | Mol. Weight : 399.45 |
Appearance : Solid | Melting Point : Not available |
| For Laboratory research use only, not for drug, household or other uses. | |
Applications : BMY-42393 is orally active and selective platelet aggregation inhibitor. BMY-42393 is also a prostacyclin partial agonist that inhibited ADP, collagen and thrombin-induced platelet aggregation (IC50 range 0.3 - 2.0 μM). BMY-42393 stimulated platelet adenylate cyclase activity (EC50 = 25 nM). Platelets treated with BMY 42393 showed an elevation of cAMP levels and activation of cAMP-dependent protein kinase. BMY 42393 also inhibited thrombin-induced elevation of intracellular free calcium. BMY 42393 competed for radiolabeled iloprost and PGE1 binding to platelet membranes (IC50; 170 nM and 130 nM, respectively).
References : Chow K. B. et al.: Br. J. Pharmacol., 134(7), 1375-84, 2001; Kam Y. et al.: Cell Signal., 13(11):841-7, 2001; Rudd J. A. et al.: Br. J. Pharmacol., 129(4), 782-90, 2000; Jones R. L. et al.: J. Cardiovasc Pharmacol. 29(4), 525-35, 1997; Wise H. et al.: Adv. Exp. Med Biol., 433, 197-200, 1997.
Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.
Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.
Site is under construction and it will coming soon. Please contact us at sales@syninnova.com for COA. Thank you!
Site is under construction and it will coming soon. Please contact us at sales@syninnova.com for HNMR. Thank you!
Recently Viewed Products |
|---|
Related Products |
|---|